Rocket Lab's Backlog Balloons to $2.36 Billion, But Margin Guidance Casts a Shadow

Rocket Lab's Q2 revenue surges 62% but margins miss, stock down 48% from peak; Iridium acquisition signals pivot to space infrastructure.

Investors are being asked to weigh two very different versions of Rocket Lab right now. One shows a company firing on all cylinders—revenue up 62 percent, a record order book, and a defense establishment that keeps writing bigger checks. The other shows a stock that has shed nearly half its value from its 52-week peak, with management guiding to margins that came in well below what Wall Street had penciled in.

The market, for now, is fixating on the latter. Shares closed Monday at €69.40, down 3.34 percent on the day, leaving the stock 48.13 percent below its 52-week high of €133.80. Yet over twelve months, the equity is still up 77.95 percent, and year-to-date gains stand at 12.85 percent.

The Numbers Behind the Tension

Rocket Lab's second-quarter 2026 results, released after Monday's close, delivered the headline growth investors have come to expect. Revenue hit $234 million, while the backlog swelled to $2.36 billion—a 137 percent jump year over year. Two large awards drove that surge: a $266 million agreement with the U.S. Space Force for the HASTE program and a $397 million order for so-called "Flatellite" satellites under the Space-Based Airborne Moving Target Indicator (SB-AMTI) initiative.

The SB-AMTI contract, announced the previous Tuesday, tasks Rocket Lab with developing, launching, and operating multiple flat satellites equipped with space-based sensors and communications links designed to deliver high bandwidth at low latency. It's a telling sign of how the U.S. security apparatus is shifting toward commercial providers that can move faster than traditional government programs.

The profitability picture, however, is less flattering. Rocket Lab posted a net loss of $49.3 million, or -€0.08 per share, versus consensus expectations of -€0.06. Management guided third-quarter GAAP gross margin to a range of 29 to 31 percent—a notable step down from the 37.6 percent analysts had anticipated. The shortfall appears tied to heavy investment in the Neutron rocket program and recent acquisitions, costs that are weighing on near-term profitability even as they build out the company's long-term capabilities.

A Strategic Pivot Beyond Rockets

The Iridium acquisition, announced alongside the quarterly figures, marks a decisive shift in Rocket Lab's identity. No longer content to simply launch payloads into orbit, the company is positioning itself as an operator of space infrastructure. Combined with the previously integrated Mynaric and Motiv businesses, the Iridium deal gives Rocket Lab its own communications networks—a vertical integration play that recasts the company as a standalone space power rather than a launch services provider.

The newly established Rocket Lab Germany GmbH subsidiary in Munich fits the same mold. The push into European satellite manufacturing is designed to reduce reliance on the U.S.-centric defense and commercial business. This expansion doesn't come cheap, but the company's cash reserves of $2.13 billion provide ample runway to fund it.

Reliability as a Competitive Moat

While the market digests the margin guidance, Rocket Lab continues to build a track record that matters more than any single contract. Thursday's launch marked the company's 92nd Electron mission and the 13th this year, carrying QPS-SAR-13, a radar satellite for Japan's Institute for Q-shu Pioneers of Space (iQPS). It was the eighth QPS-SAR delivery for the customer, with Rocket Lab touting a perfect success rate on that particular configuration.

That reliability is the quiet engine of the business. In an industry where a single failed launch can scare off customers for years, consistency is the ultimate sales pitch. The relationship with iQPS has deepened accordingly: in late July, the two sides agreed to three more dedicated Electron missions—the third time iQPS has booked multiple launches within a year. Recurring orders like these spread fixed costs across more flights and provide the planning certainty that single contracts cannot.

Chart Position and the Road Ahead

Technically, the stock is in a consolidation phase rather than a breakdown. It currently sits just 2.45 percent above its 200-day moving average of €67.74, a support level that has held so far. The 9.56 percent gap below the 50-day average tells a different story, though—the market is still processing the earnings miss. Add to that the uncertainty surrounding Neutron's first flight, scheduled for the fourth quarter of 2026 but potentially slipping into 2027, and there's plenty for cautious investors to chew on.

The average analyst price target stands at €96.35, implying upside of 38.8 percent from Monday's close. Reaching that level likely hinges on two variables: the smooth integration of Iridium and Neutron launching on schedule.

With annualized 30-day volatility at 86.80 percent, Rocket Lab remains a high-octane holding by any measure. The bull case rests on the $2.36 billion backlog as evidence of structural demand rather than a company in distress. The bear case points to margin compression and a valuation that may have gotten ahead of operational reality. Both narratives contain truth—the coming quarters will determine which one wins out.